Lim
Cheong
Guan
Executive
Director
Medi-flex
Limited
Lot 124
& 126,
Jalan
Lapan
Kompleks
Olak
Lempit,
KM 13
Jalan
Banting-Dengkil
42700
Banting
Selangor
Darul
Ehsan
Dear
Sir,
QUERY
REGARDING
TRADING
ACTIVITY
We have
noted,
and draw
to your
attention,
a
substantial
increase
in the
price of
your
shares
recently.
To
ensure a
fair,
orderly
and
transparent
market,
please
answer
each of
the
following:
Question
1: Are
you
aware of
any
information
not
previously
announced
concerning
you (the
issuer),
your
subsidiaries
or
associated
companies
which,
if
known,
might
explain
the
trading?
- If
yes, the
information
must be
announced
immediately.
Question
2: Are
you
aware of
any
other
possible
explanation
for the
trading?
Question
3: Can
you
confirm
your
compliance
with the
listing
rules
and, in
particular,
listing
rule
703?
Please
respond
immediately
via
SGXNET.
Where
appropriate,
you may
want to
request
a
trading
halt or
a
suspension
of
trading.
Please
contact
Market
Control
(or, if
you need
to
discuss
the
matter,
your
Account
Manager
in
Issuer
Regulation)
immediately.
Thank
you for
your
cooperation.
Notes:
1.
Subject
to
limited
exceptions
in rule
703, an
issuer
must
announce
any
information
known to
the
issuer
concerning
it or
any of
its
subsidiaries
or
associated
companies
which is
necessary
to avoid
the
establishment
of a
false
market
in the
issuer’s
securities,
or would
be
likely
to
materially
affect
the
price or
value of
its
securities
must be
publicly
disclosed
(rule
703).
2. An
issuer
must
undertake
a review
to
determine
the
causes
of any
unusual
trading
activity
(paragraph
20 of
Appendix
7.1).
3. An
announcement
should,
among
other
things,
state
whether
the
issuer
or any
of its
directors
are
aware of
the
reasons
for the
unusual
trading
activity
and
whether
there is
any
material
information
which
has not
been
publicly
disclosed
(paragraph
31 of
Appendix
7.1).
4. Your
responsibility
under
listing
rules is
not
confined
to, or
necessarily
satisfied
by,
answering
the
questions
in this
letter.
